IL6 and cancer: CD10+GPR77+ CAFs supply the TME with IL-8 and IL-6, which through the activation of NF-κB signaling via p65 phosphorylation and acetylation, protect cancer stem cells from chemotherapy-induced cell death [110,111,112].